ERBB2 and neoplasm: Fresh‐frozen tumor biopsies taken before, during, and after treatment from human epidermal growth factor receptor 2 negative non‐metastatic patients receiving neoadjuvant chemotherapy with or without bevacizumab were subjected to molecular profiling.